Navigation Links
USC wins $56.8M NIH award for clinical and translational research
Date:7/15/2010

The University of Southern California (USC) has received a prestigious $56.8 million Clinical and Translational Science Award from the National Institutes of Health (NIH) to support and promote scientific discoveries and their application in real-life settings to health and health care. The CTSA will have an important focus on health issues of people living in densely populated urban environments.

The award, which will be distributed over the next five years, was given to the USC-based Los Angeles Basin Clinical and Translational Science Institute (CTSI). CTSI was established in 2006 to connect basic scientists to clinical and community researchers and practitioners with a goal of accelerating the translation of laboratory discoveries into practice. Principal investigator is Thomas A. Buchanan, M.D., director of the Los Angeles Basin CTSI, and associate dean for clinical research at the Keck School of Medicine of USC.

"We congratulate principal investigator Dr. Tom Buchanan and the highly interdisciplinary USC team for winning this award," said Carmen A. Puliafito, M.D., M.B.A., dean of the Keck School of Medicine. "An extraordinarily strong grant application resulted in USC receiving the first Clinical and Translational Science Award in Los Angeles." The application received a score of 12 on a scale of 10 to 90 (10 is a perfect score).

Faculty from eight USC schools and Childrens Hospital Los Angeles will partner with Kaiser Permanente Southern California, the Los Angeles County departments of Health Services and Mental Health, the Community Clinic Association of Los Angeles County, and more than 30 community health organizations in greater Los Angeles to address the specific needs of the urban and diverse patient populations found in USC's backyard of downtown Los Angeles.

"We positioned our CTSI as not only an institute focused on health research, but also as a partnership among some of the largest providers of health care in Los Angeles. We are working collaboratively with others on campus and off campus, using L.A. as a real world laboratory to address issues that are important to the community here," Buchanan said.

With this award, USC joins a consortium of 55 health research centers in 28 states and the District of Columbia that are developing new ways to advance medical research in many disease areas and conditions, including cancer, mental illness, neurological disorders, cardiovascular disease, diabetes and obesity.

The selected research institutions work together as a national consortium to improve the way biomedical research is conducted across the country. The consortium, funded through the Clinical and Translational Science Awards (CTSA), shares a common vision to reduce the time it takes for laboratory discoveries to become treatments for patients, and to engage communities in clinical research efforts. It also is fulfilling the critical need to train a new generation of clinical researchers. The CTSA program is led by the National Center for Research Resources, part of National Institutes of Health.

USC competed for the award against 38 other institutions, including three major academic institutions in Southern California. Nine institutions received grant awards this year, and the NIH has stated that it plans to implement a maximum of 60 Clinical and Translational Science Awards overall.

While USC's Los Angeles Basin CTSI has already been successful at launching community research and interdisciplinary projects on a small scale, large-scale funding from the new NIH award will open the doors to development of a premier clinical and translational institute with the potential for a very large impact on health research and health care.

The Los Angeles Basin CTSI has four main goals for the CTSA. The first is to create an integrated academic environment that promotes and supports clinical and translational research. The second is to develop new interdisciplinary teams and projects to address top research priorities and health issues of people living in urban environments. The third is to train a new generation of investigators for clinical and translational science. The fourth goal is to share research findings locally, through the CTSI partnership, and nationally, through the consortium of institutions with CTSAs, to foster better health.

The CTSI has secured participation of eight schools at USC, including Medicine, Cinematic Arts, Dentistry, Education, Engineering, Law, Pharmacy and Social Work.

Some interdisciplinary projects are currently under way. For example, leveraging talent from health sciences, engineering, cinema and informatics, faculty members recently developed an interactive computer game that helps autistic children better interact on an emotional level, one of the deficits of those with the disorder.


'/>"/>

Contact: Leslie Ridgeway
leslie.ridgeway@usc.edu
323-442-2823
University of Southern California
Source:Eurekalert

Related biology news :

1. NIH doles out $3M in new innovator awards to 2 UC San Diego faculty
2. Wistar Institute researcher receives New Innovator award from NIH
3. Stevens awarded $1M for advanced biofuels research
4. NIH awards Clemson bioengineer $1.5 million to improve durability of tissue heart valves
5. L-1 Identity Solutions Awarded New Massachusetts RMV Drivers License Contract Valued at an Estimated $32 Million
6. Entomological Society of America names 2008 award winners
7. 8 National Medals of Science awardees to be honored at gala, then the White House
8. BIO-keys(R) Law Enforcement Group Awarded $700,000 in New Contracts
9. Broad Institute awarded major grant to bolster epigenomics research
10. Entertainment Software Association Foundation awards grant to FAS for immune attack
11. Audience Selected as Silver Winner in This Years Wall Street Journal Technology Innovation Awards and Winner of the Semiconductors Category
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... 2017   ivWatch LLC , a medical device company focused ... announced receipt of its ISO 13485 Certification, the global standard for ... for Standardization (ISO®). ... 400 Continuous Monitoring device for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, ...
(Date:6/14/2017)... IBM ) is introducing several innovative partner startups at ... between startups and global businesses, taking place in ... startups will showcase the solutions they have built with IBM ... France is one of the most ... increase in the number of startups created between 2012 and ...
(Date:5/6/2017)... SINGAPORE , May 5, 2017 ... has just announced a new breakthrough in biometric ... that exploits quantum mechanical properties to perform ... new smart semiconductor material created by Ram Group ... across finance, entertainment, transportation, supply chains and security. ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights ... (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... innovation and business process optimization firm for the life sciences and healthcare industries, ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile ...
(Date:10/9/2017)... , ... October 09, 2017 , ... ... four-tiered line of medical marijuana products targeting the needs of consumers who are ... of Kindred takes place in Phoenix, Arizona. , As operators of two successful ...
Breaking Biology Technology: